Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Antidiabetic Thiazolidinediones market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antidiabetic Thiazolidinedionesmarket, defines the market attractiveness level of Antidiabetic Thiazolidinediones market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antidiabetic Thiazolidinediones industry, describes the types of Antidiabetic Thiazolidinediones market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antidiabetic Thiazolidinediones market and the development prospects and opportunities of Antidiabetic Thiazolidinediones industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antidiabetic Thiazolidinediones market in Chapter 13.
By Player:
Pfizer
Novo Nordisk
AstraZeneca
Bristol-Myers Squibb
Takeda Pharmaceuticals
Merck & Co
Boehringer Ingelheim
Sanofi
Eli Lilly
GlaxoSmithKline
By Type:
Rosiglitazone
Pioglitazone
By End-User:
Hospitals
Clinics
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antidiabetic Thiazolidinediones Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antidiabetic Thiazolidinediones Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antidiabetic Thiazolidinediones Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antidiabetic Thiazolidinediones Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antidiabetic Thiazolidinediones Market Analysis and Outlook to 2022
-
7.1 Global Antidiabetic Thiazolidinediones Consumption (2017-2022)
-
7.2 United States Antidiabetic Thiazolidinediones Consumption (2017-2022)
-
7.3 Europe Antidiabetic Thiazolidinediones Consumption (2017-2022)
-
7.4 China Antidiabetic Thiazolidinediones Consumption (2017-2022)
-
7.5 Japan Antidiabetic Thiazolidinediones Consumption (2017-2022)
-
7.6 India Antidiabetic Thiazolidinediones Consumption (2017-2022)
-
7.7 South Korea Antidiabetic Thiazolidinediones Consumption (2017-2022)
8 Region and Country-wise Antidiabetic Thiazolidinediones Market Analysis and Outlook to 2028
-
8.1 Global Antidiabetic Thiazolidinediones Consumption Forecast (2022-2028)
-
8.2 United States Antidiabetic Thiazolidinediones Consumption Forecast (2022-2028)
-
8.3 Europe Antidiabetic Thiazolidinediones Consumption Forecast (2022-2028)
-
8.4 China Antidiabetic Thiazolidinediones Consumption Forecast (2022-2028)
-
8.5 Japan Antidiabetic Thiazolidinediones Consumption Forecast (2022-2028)
-
8.6 India Antidiabetic Thiazolidinediones Consumption Forecast (2022-2028)
-
8.7 South Korea Antidiabetic Thiazolidinediones Consumption Forecast (2022-2028)
9 Global Antidiabetic Thiazolidinediones Market Outlook by Types and Applications to 2022
-
9.1 Global Antidiabetic Thiazolidinediones Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Rosiglitazone Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Pioglitazone Consumption and Growth Rate (2017-2022)
-
9.2 Global Antidiabetic Thiazolidinediones Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Antidiabetic Thiazolidinediones Market Outlook by Types and Applications to 2028
-
10.1 Global Antidiabetic Thiazolidinediones Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Rosiglitazone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Pioglitazone Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antidiabetic Thiazolidinediones Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Antidiabetic Thiazolidinediones Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antidiabetic Thiazolidinediones Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antidiabetic Thiazolidinediones Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antidiabetic Thiazolidinediones Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antidiabetic Thiazolidinediones Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Antidiabetic Thiazolidinediones Product and Service
-
14.2 Novo Nordisk
-
14.2.1 Novo Nordisk Company Details
-
14.2.2 Novo Nordisk Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novo Nordisk Antidiabetic Thiazolidinediones Product and Service
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Details
-
14.3.2 AstraZeneca Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AstraZeneca Antidiabetic Thiazolidinediones Product and Service
-
14.4 Bristol-Myers Squibb
-
14.4.1 Bristol-Myers Squibb Company Details
-
14.4.2 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Product and Service
-
14.5 Takeda Pharmaceuticals
-
14.5.1 Takeda Pharmaceuticals Company Details
-
14.5.2 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Product and Service
-
14.6 Merck & Co
-
14.6.1 Merck & Co Company Details
-
14.6.2 Merck & Co Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck & Co Antidiabetic Thiazolidinediones Product and Service
-
14.7 Boehringer Ingelheim
-
14.7.1 Boehringer Ingelheim Company Details
-
14.7.2 Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Boehringer Ingelheim Antidiabetic Thiazolidinediones Product and Service
-
14.8 Sanofi
-
14.8.1 Sanofi Company Details
-
14.8.2 Sanofi Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi Antidiabetic Thiazolidinediones Product and Service
-
14.9 Eli Lilly
-
14.9.1 Eli Lilly Company Details
-
14.9.2 Eli Lilly Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Eli Lilly Antidiabetic Thiazolidinediones Product and Service
-
14.10 GlaxoSmithKline
-
14.10.1 GlaxoSmithKline Company Details
-
14.10.2 GlaxoSmithKline Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 GlaxoSmithKline Antidiabetic Thiazolidinediones Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antidiabetic Thiazolidinediones
-
Figure Antidiabetic Thiazolidinediones Picture
-
Table Global Antidiabetic Thiazolidinediones Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antidiabetic Thiazolidinediones Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antidiabetic Thiazolidinediones Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antidiabetic Thiazolidinediones Consumption by Country (2017-2022)
-
Figure United States Antidiabetic Thiazolidinediones Consumption and Growth Rate (2017-2022)
-
Table Europe Antidiabetic Thiazolidinediones Consumption and Growth Rate (2017-2022)
-
Figure China Antidiabetic Thiazolidinediones Consumption and Growth Rate (2017-2022)
-
Figure Japan Antidiabetic Thiazolidinediones Consumption and Growth Rate (2017-2022)
-
Figure India Antidiabetic Thiazolidinediones Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antidiabetic Thiazolidinediones Consumption and Growth Rate (2017-2022)
-
Figure Global Antidiabetic Thiazolidinediones Consumption Forecast by Country (2022-2028)
-
Figure United States Antidiabetic Thiazolidinediones Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antidiabetic Thiazolidinediones Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antidiabetic Thiazolidinediones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antidiabetic Thiazolidinediones Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antidiabetic Thiazolidinediones Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antidiabetic Thiazolidinediones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rosiglitazone Consumption and Growth Rate (2017-2022)
-
Figure Global Pioglitazone Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Rosiglitazone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pioglitazone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antidiabetic Thiazolidinediones Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antidiabetic Thiazolidinediones Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Antidiabetic Thiazolidinediones Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Antidiabetic Thiazolidinediones Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Antidiabetic Thiazolidinediones Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Antidiabetic Thiazolidinediones Product and Service
-
Table Takeda Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Antidiabetic Thiazolidinediones Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Antidiabetic Thiazolidinediones Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Antidiabetic Thiazolidinediones Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Antidiabetic Thiazolidinediones Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Antidiabetic Thiazolidinediones Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Antidiabetic Thiazolidinediones Product and Service
-
